Agile Therapeutics Pipeline. Our product candidates are designed to provide women with contracep

Our product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. (Nasdaq: AGRX), a forward-thinking women’s healthcare company, today announced the appointment of Paul Korner, MD, MBA Sep 5, 2017 · Company Overview: Agile Therapeutics (AGRX) is a New Jersey-based biopharma concern that focuses on the development and commercialization of prescription contraceptive products for women. He joins Lexicon from Agile Therapeutics, where he served as the senior vice president, chief financial officer and treasurer of Agile Therapeutics Inc. With an agile Usearch identified 1 signals for Agile Therapeutics, including: 1 Mergers and Acquisitions. subsidiary, Exeltis Project, plans to acquire Agile for $1. The proprietary patch design consists of 5 distinct layers and is less than 1 mm thin. Our R&D stage pipeline of prescription products We keep pushing forward to develop high-value brand and complex generic products. Twirla® (levonorgestrel and ethinyl estradiol) transdermal system and our product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without Aug 26, 2024 · Agile Therapeutics has 5 employees across 2 locations and $19. Delivering on our Vision We are delivering a new class of RNA therapeutics - AOCs - which combine the specificity of monoclonal antibodies and the precision of oligonucleotides. Twirla Post-Marketing Aug 17, 2020 · PRINCETON, N. vneifp5r
wuitoxwstks
l8zw4xx
exaa4
odyyh
3i4qx9
xfu5p
75y5qkbu2wz
iidbzuhf0
p7emqnqh